GDRX News & Events

In a regulatory filing, the company stated, "On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, effective April 3, 2026 in order to pursue other opportunities. Nabiey will remain an employee of the company through June 8, 2026 to support the transition of his responsibilities. Nabiey's resignation was not a result of any disagreement between the company and Nabiey on any matter related to the operations, policies, or practices of the company."

GoodRx (GDRX) announced employer-sponsored access to Zepbound KwikPen through GoodRx Employer Direct. As one of Eli Lilly's (LLY) Employer Connect independent program administrators, GoodRx enables self-insured employers to access Zepbound KwikPen at a set price of $449 across all doses, with the flexibility to further subsidize the cost for employees at the pharmacy counter.